188 related articles for article (PubMed ID: 19793339)
21. Prognostic and microRNA profile analysis for CD44 positive expression pediatric posterior fossa ependymoma.
Shu C; Wang Q; Yan X; Wang J
Clin Transl Oncol; 2018 Nov; 20(11):1439-1447. PubMed ID: 29704232
[TBL] [Abstract][Full Text] [Related]
22. Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation.
Neyazi S; Yamazawa E; Hack K; Tanaka S; Nagae G; Kresbach C; Umeda T; Eckhardt A; Tatsuno K; Pohl L; Hana T; Bockmayr M; Kim P; Dorostkar MM; Takami T; Obrecht D; Takai K; Suwala AK; Komori T; Godbole S; Wefers AK; Otani R; Neumann JE; Higuchi F; Schweizer L; Nakanishi Y; Monoranu CM; Takami H; Engertsberger L; Yamada K; Ruf V; Nomura M; Mohme T; Mukasa A; Herms J; Takayanagi S; Mynarek M; Matsuura R; Lamszus K; Ishii K; Kluwe L; Imai H; von Deimling A; Koike T; Benesch M; Kushihara Y; Snuderl M; Nambu S; Frank S; Omura T; Hagel C; Kugasawa K; Mautner VF; Ichimura K; Rutkowski S; Aburatani H; Saito N; Schüller U
Acta Neuropathol; 2024 Jan; 147(1):22. PubMed ID: 38265489
[TBL] [Abstract][Full Text] [Related]
23. Long-Term Surgical Resection Outcomes of Pediatric Myxopapillary Ependymoma: Experience of Two Centers and Brief Literature Review.
Abdallah A; Emel E; Gündüz HB; Sofuoğlu ÖE; Asiltürk M; Abdallah BG
World Neurosurg; 2020 Apr; 136():e245-e261. PubMed ID: 31899399
[TBL] [Abstract][Full Text] [Related]
24. MRI Phenotype of RELA-fused Pediatric Supratentorial Ependymoma.
Nowak J; Jünger ST; Huflage H; Seidel C; Hohm A; Vandergrift LA; von Hoff K; Rutkowski S; Pietsch T; Warmuth-Metz M
Clin Neuroradiol; 2019 Dec; 29(4):595-604. PubMed ID: 30027327
[TBL] [Abstract][Full Text] [Related]
25. Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior.
Swanson AA; Raghunathan A; Jenkins RB; Messing-Jünger M; Pietsch T; Clarke MJ; Kaufmann TJ; Giannini C
J Neuropathol Exp Neurol; 2019 Sep; 78(9):791-797. PubMed ID: 31373367
[TBL] [Abstract][Full Text] [Related]
26. Primary multifocal myxopapillary ependymoma of the filum terminale.
Khalatbari MR; Hamidi M; Moharamzad Y; Shobeiri E
J Neurosurg Sci; 2016 Dec; 60(4):424-9. PubMed ID: 26154385
[TBL] [Abstract][Full Text] [Related]
27. Spinal extramedullary anaplastic ependymoma with spinal and intracranial metastases.
Schuurmans M; Vanneste JA; Verstegen MJ; van Furth WR
J Neurooncol; 2006 Aug; 79(1):57-9. PubMed ID: 16614942
[TBL] [Abstract][Full Text] [Related]
28. Survival and Prognostic Factors of Adult Intracranial Ependymoma: A Single-institutional Analysis of 236 Patients.
Zhao F; Wu T; Wang LM; Zhang J; Zhang H; Li SW; Zhang S; Li P; Wang B; Luo L; Liu PN
Am J Surg Pathol; 2021 Jul; 45(7):979-987. PubMed ID: 33739788
[TBL] [Abstract][Full Text] [Related]
29. High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma.
Raffeld M; Abdullaev Z; Pack SD; Xi L; Nagaraj S; Briceno N; Vera E; Pittaluga S; Lopes Abath Neto O; Quezado M; Aldape K; Armstrong TS; Gilbert MR
Acta Neuropathol Commun; 2020 Jul; 8(1):101. PubMed ID: 32641156
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of Long Noncoding RNA HOTAIR Is a Unique Epigenetic Characteristic of Myxopapillary Ependymoma.
Zheng H; Baranova K; Song J; Yan L; Biswas S; Chakrabarti S; Zhang Q
J Neuropathol Exp Neurol; 2020 Nov; 79(11):1193-1202. PubMed ID: 32940681
[TBL] [Abstract][Full Text] [Related]
31. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.
Witt H; Gramatzki D; Hentschel B; Pajtler KW; Felsberg J; Schackert G; Löffler M; Capper D; Sahm F; Sill M; von Deimling A; Kool M; Herrlinger U; Westphal M; Pietsch T; Reifenberger G; Pfister SM; Tonn JC; Weller M;
Neuro Oncol; 2018 Nov; 20(12):1616-1624. PubMed ID: 30053291
[TBL] [Abstract][Full Text] [Related]
32. TERTp Mutation Detection in Plasma by Droplet-Digital Polymerase Chain Reaction in Spinal Myxopapillary Ependymoma with Lung Metastases.
Deniel A; Marguet F; Beaussire L; Tobenas-Dujardin AC; Peillon C; Gambirasio MA; Veresezan O; Magne N; Di Fiore F; Laquerrière A; Sarafan-Vasseur N; Fontanilles M
World Neurosurg; 2019 Oct; 130():405-409. PubMed ID: 31330336
[TBL] [Abstract][Full Text] [Related]
33. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
Abdulaziz M; Mallory GW; Bydon M; De la Garza Ramos R; Ellis JA; Laack NN; Marsh WR; Krauss WE; Jallo G; Gokaslan ZL; Clarke MJ
Neurosurg Focus; 2015 Aug; 39(2):E8. PubMed ID: 26235025
[TBL] [Abstract][Full Text] [Related]
34. Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series.
Benesch M; Mynarek M; Witt H; Warmuth-Metz M; Pietsch T; Bison B; Pfister SM; Pajtler KW; Kool M; Schüller U; Pietschmann K; Juhnke BO; Tippelt S; Fleischhack G; Schmid I; Kramm CM; Vorwerk P; Beilken A; Classen CF; Hernáiz Driever P; Kropshofer G; Imschweiler T; Lemmer A; Kortmann RD; Rutkowski S; von Hoff K
Oncologist; 2019 Sep; 24(9):e921-e929. PubMed ID: 30850560
[TBL] [Abstract][Full Text] [Related]
35. Is NF2 a Key Player of the Differentially Expressed Gene Between Spinal Cord Ependymoma and Intracranial Ependymoma?
Kim KT; Lee CH; Chung CK; Kim JH
World Neurosurg; 2018 Oct; 118():e906-e917. PubMed ID: 30031196
[TBL] [Abstract][Full Text] [Related]
36. Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity.
Prayson RA
Mod Pathol; 1997 Apr; 10(4):304-10. PubMed ID: 9110291
[TBL] [Abstract][Full Text] [Related]
37. Myxopapillary ependymoma with anaplastic features.
Awaya H; Kaneko M; Amatya VJ; Takeshima Y; Oka S; Inai K
Pathol Int; 2003 Oct; 53(10):700-3. PubMed ID: 14516321
[TBL] [Abstract][Full Text] [Related]
38. MYCN amplification drives an aggressive form of spinal ependymoma.
Ghasemi DR; Sill M; Okonechnikov K; Korshunov A; Yip S; Schutz PW; Scheie D; Kruse A; Harter PN; Kastelan M; Wagner M; Hartmann C; Benzel J; Maass KK; Khasraw M; Sträter R; Thomas C; Paulus W; Kratz CP; Witt H; Kawauchi D; Herold-Mende C; Sahm F; Brandner S; Kool M; Jones DTW; von Deimling A; Pfister SM; Reuss DE; Pajtler KW
Acta Neuropathol; 2019 Dec; 138(6):1075-1089. PubMed ID: 31414211
[TBL] [Abstract][Full Text] [Related]
39. Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial.
Upadhyaya SA; Robinson GW; Onar-Thomas A; Orr BA; Billups CA; Bowers DC; Bendel AE; Hassall T; Crawford JR; Partap S; Fisher PG; Tatevossian RG; Seah T; Qaddoumi IA; Vinitsky A; Armstrong GT; Sabin ND; Tinkle CL; Klimo P; Indelicato DJ; Boop FA; Merchant TE; Ellison DW; Gajjar A
Neuro Oncol; 2019 Oct; 21(10):1319-1330. PubMed ID: 30976811
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry.
Prayson RA
Ann Diagn Pathol; 1999 Feb; 3(1):11-8. PubMed ID: 9990108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
